Global cancer cases could rise to nearly 35 million a year by 2050, according to the World Health Organization’s (WHO) Global Status Report on Cancer 2026, a projection that highlights widening gaps in prevention, diagnosis and treatment.
The trend demands urgent action.
Projected surge and regional disparities
The report notes that the world currently sees about 20.6 million new cancer cases and close to 10 million deaths each year, making cancer the second leading cause of death after cardiovascular disease. If current trends continue, new cases may climb to almost 35 million annually by mid‑century.
Asia bears the largest share of the burden. In 2024 the region accounted for 50.7 % of all new cases and 56.5 % of deaths, reflecting its population size rather than a higher per‑capita risk. Europe contributed 21 % of cases and 20 % of deaths despite representing only about 9 % of the global population. Many African nations and some Asian countries report fewer cases but experience higher mortality rates, highlighting inequities in access to care.
Women diagnosed with breast cancer in high‑income nations enjoy an 87 % five‑year survival rate, while the figure drops to roughly 42 % in low‑income settings. Fewer than one‑third of countries have incorporated cancer care into universal health coverage, leaving large segments of the population without essential services.
Related: Pharmacy in Indonesia Early Development
Risk factors and prevention efforts
Nearly 40 % of cancers worldwide are linked to preventable risk factors, including tobacco use, alcohol consumption, excess body weight, physical inactivity and infections such as human papillomavirus, hepatitis B and C, and Helicobacter pylori. Dr. Elisabete Weiderpass, director of the International Agency for Research on Cancer, said that while some nations have seen declines in specific cancers after adopting prevention policies, progress has been slower than hoped.
For patients, the growing numbers translate into tangible hardships. WHO’s first global survey of people affected by cancer found that at least 45 % experience financial strain, more than half report mental‑health challenges, and nearly all caregivers face unpaid duties and social isolation.
In practice, the surge means that families in low‑resource settings may confront even greater obstacles when a loved one is diagnosed. Without affordable medicines or nearby treatment centers, the disease can erode household incomes and limit future opportunities for children, reinforcing cycles of poverty. This reality pushes the need for a people‑centered approach that aligns health‑system design with everyday experiences.
Access to medicines and research outlook
Research activity is on the rise, with registered clinical trials increasing by an average of 7.3 % per year between 2005 and 2021. Nonetheless, the report stresses that innovation must be matched with public‑health priorities to ensure equitable outcomes.
WHO calls on governments, international bodies, academia, civil society, the private sector and health agencies to place patients and families at the core of cancer‑care strategies. The organization’s seven recommendations focus on strengthening capabilities, protecting patients through better social programs, and delivering value by aligning research with health‑system needs.
